EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A guide to selecting high-performing antibodies for DJ-1 (PARK7) (Q99497) for use in western blot, immunoprecipitation, and immunofluorescence

CongYao Zha, Charles Alende iD, Maryam Fotouhi, Sara González Bolívar iD, Riham Ayoubi, Vincent Francis iD, Peter S McPherson, Carl Laflamme iD

F1000Research · 2026

DOI: 10.12688/f1000research.182633.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, 2026. Verfasst von CongYao Zha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Protein Deglycase DJ-1, Immunoprecipitation, Blotting, Western, Antibodies. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DJ-1 is a multifunctional protein that plays a pivotal role in cellular protection against oxidative stress and neurodegeneration. Mutations in the PARK7 gene are associated with early-onset familial Parkinson’s disease. Here we have characterized sixteen DJ-1 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While the use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Deglycase DJ-1ImmunoprecipitationBlotting, WesternAntibodiesFluorescent Antibody TechniqueHumans

Stichwörter der Autor:innen

DJ-1PARK7Parkinson disease protein 7UniProt ID Q99497antibody characterizationantibody validationimmunofluorescenceimmunoprecipitationwestern blot

Substanzen

Protein Deglycase DJ-1PARK7 protein, humanAntibodies

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Canada.

ORCID-Profile: Charles Alende, Sara González Bolívar, Vincent Francis, Carl Laflamme

Zitieren

APA

Zha, C., Alende, C., Fotouhi, M., Bolívar, S. G., Ayoubi, R., Francis, V., McPherson, P. S., & Laflamme, C. (2026). A guide to selecting high-performing antibodies for DJ-1 (PARK7) (Q99497) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.182633.1

Vancouver

Zha C, Alende C, Fotouhi M, Bolívar SG, Ayoubi R, Francis V, et al. A guide to selecting high-performing antibodies for DJ-1 (PARK7) (Q99497) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2026. doi:10.12688/f1000research.182633.1

BibTeX
@article{Zha2026,
  author = {Zha, CongYao and Alende, Charles and Fotouhi, Maryam and Bolívar, Sara González and Ayoubi, Riham and Francis, Vincent and McPherson, Peter S and Laflamme, Carl},
  title = {A guide to selecting high-performing antibodies for DJ-1 (PARK7) (Q99497) for use in western blot, immunoprecipitation, and immunofluorescence},
  journal = {F1000Research},
  year = {2026},
  doi = {10.12688/f1000research.182633.1}
}
Kostenlos starten →